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Background: The clinical application of cell therapy may be enhanced by obtaining cells non-invasively and by utilizing cells with a wide 
differentiation profile. Unrestricted somatic stem cells (USSC) may possess these advantages. Furthermore, inducing cells down a cardiomyocyte or 
angiogenic lineage may enhance their effect in cardiac repair. Herein, we investigate the potential for USSC to differentiate into a novel genotype, 
and we explore the effect of USSC and pre-conditioned USSC (cUSSC) in an in vivo model of ischemic heart disease.
Methods: We pre-conditioned USSC by 24 hour exposure to 50ng/ml bFGF, 20ng/ml HGF and 20ng/ml BMP2. Cardiac troponin T, `-myosin heavy 
chain and GATA4 expression was assessed using immunofluorescence. Microarray was used to define the novel genotype that was thus generated 
(results confirmed by RT-PCR). We administered 4x106 USSC and 4x106 cUSSC to a rat model of cardiac disease. Cardiac function was assessed by 
transthoracic echocardiography. Infarct size, angiogenesis and apoptosis were assessed using histology and immunohistochemistry.
Results: Pre-conditioning of USSC did not enhance the expression of cardiac troponin T, `-myosin heavy chain and GATA4. Microarray analysis 
revealed up-regulation of angiogenic factors (members of the FGF super-family, angiopoietin proteins and VEGF-like proteins). Cardiac specific 
genes were not dysregulated. USSC delivery post-myocardial infarction (MI) improved ejection fraction (EF) to 66.5%, significantly greater then 
MI only (39.7%, p<0.001) and media (41.2%, p<0.001). Delivery of cUSSC improved EF to 65.6% (p=0.001 vs MI only, p=0.001 vs media). There 
was no difference in EF between USSC and cUSSC (p=1.0). Infarct size did not differ between groups (p=0.35). There was a trend towards greater 
angiogenesis (p=0.055) and less apoptosis (p=0.068) in the border zone of the infarct of treated animals.
Conclusions: USSC can differentiate into cells with enhanced angiogenic gene expression. USSC administration improves cardiac function post-MI, 
and this benefit was not augmented by pre-conditioning. It is postulated that the benefit is due to modification of the cellular processes caused by 
local cytokines.
